Evidence strength for the context described on this page.
PEPTIDE ATLAS / SKIN & HAIR / COLLAGEN PEPTIDES
Food supplement / cosmeticModerate
Collagen peptides
ALSO KNOWN ASHydrolyzed collagen
A food-derived peptide supplement with modest evidence for selected skin and joint outcomes.
01CATEGORYSkin & hair
02REGULATORY STATUSFood supplement / cosmetic
03COMMON ROUTEOral powder, drink or capsule
04DOSE BASISStudy / product context
HOW TO USE THIS PAGE
Read the profile in the order that protects the decision.
- 01Verify what it is
Confirm the exact molecule, route, regulatory lane and actual human evidence.
- 02Read limits before dose
Unsupported claims, contraindications and uncertainty come before any protocol.
- 03Build the monitoring plan
Define the target, baseline checks, reassessment point and stop rules with a qualified clinician.
RESEARCH PASSPORT
The five facts to know first.
REVIEWED
JULY 2026
Status is product-, formulation- and indication-specific.
Trial, label or reported-practice basis is always named.
Official labels, regulators, trials and indexed literature where available.
Peptide hormones, growth factors and related substances may be prohibited.
Check Global DRO ↗OVERVIEW
What Collagen peptides is.
Enzymatically hydrolyzed animal collagen consumed as a protein supplement. It is not the same type of product or regulatory category as an injectable signaling peptide.
HOW IT IS THOUGHT TO WORK
Provides collagen-rich amino acids and small peptides that may influence connective-tissue turnover; it is not a complete protein.
EFFECTS & EVIDENCE
What the evidence supports—and what it does not.
- Modest average improvements in skin hydration or elasticity in some trials
- Possible modest benefit for joint symptoms in some populations
- Convenient source of glycine-rich protein
- Replacing sunscreen, retinoids or adequate complete protein
- Targeted delivery directly to wrinkles or tendons
- Large hair-regrowth effects
Evidence grade: Moderate. For an approved drug, “high” refers only to its labeled indication—not every off-label or wellness claim.
DOSAGE CONTEXT
Best available dosing range.
STUDY / PRODUCT CONTEXTCommon study amounts range from about 2.5–10 g/day for skin outcomes and 5–15 g/day in connective-tissue or joint research, depending on product and endpoint.
- Route
- Oral powder, drink or capsule
- Duration
- Usually 8–12 weeks before judging skin outcomes; longer for some joint studies
- Men & women
- No established lower dose for women; total protein needs and body size matter more.
Clinician verification required. Always double-check the exact molecule or salt, concentration, route, volume, schedule, indication, patient-specific contraindications, interactions and applicable law with the prescribing clinician and dispensing pharmacy. A disclaimer does not make an unapproved product FDA-approved, and a reported-use range is not a prescription.
MONITORING
What should be tracked.
- Total daily protein
- GI tolerance
- Product allergen and third-party quality testing
SAFETY
Risks, red flags and reasons to avoid it.
- Allergic reaction to source material
- GI discomfort
- Contaminants or inaccurate protein labeling in poor-quality products
- Known allergy to the source species
- Using collagen as the only major protein source
Stop and seek careGet urgent medical help for trouble breathing, facial or throat swelling, chest pain, fainting, severe persistent abdominal pain, neurologic changes, severe hypoglycemia, uncontrolled vomiting or a prolonged painful erection.
CLINICIAN VISIT CHECKLIST
Six questions worth bringing with you.
Molecule or analog, salt, concentration, route, manufacturer or compounder, lot and beyond-use date.
Name the diagnosis or target, how it will be measured and the realistic time to reassess.
Ask how it compares with FDA-approved, lower-risk or better-studied alternatives.
Label, human trial, specialty guideline or clinic convention—and whether that route and formulation match.
Baseline checks, follow-up measures, interactions, pregnancy considerations and symptoms that mean stop.
Pharmacy license, prescription, identity/potency testing, sterility controls and who handles a product complaint.
Do not improvise reconstitution or convert “units” without the exact concentration. Mixing, storage and beyond-use instructions are product-specific; confirm them with the dispensing pharmacy.
PRIMARY SOURCES
Read the record yourself.
We prioritize official prescribing information, FDA regulatory material, registered trials and indexed biomedical literature. A source supports the specific statement beside it—not every claim made about the molecule.
PRODUCTS & TREATMENT ACCESS
Choose a tested finished product.
Over-the-counter dietary supplement; product quality varies.
This is one of the lower-risk peptide categories, but the expected effect is modest and product sourcing still matters.
Compare quality-first products
Coming soon: identity testing, contaminant screening, transparent sourcing and dose-per-serving comparisons.
Get the product shortlist →NEXT STEP